Armata Pharmaceuticals Inc. (ARMP): Share Price, Stock Analysis, Annual Report | Value Research Get Armata Pharmaceuticals Inc. (ARMP)'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house.
info-circle
company-logo

Click to see a quick summary and important updates about this stock!Dismiss

  • Healthcare
  • Biotechnology & Pharma Research

Armata Pharmaceuticals Inc. (ARMP)

NYSE: ARMP

  • Market Capitalisation info

    $152 Mln


  • 12 Month Earnings info

    $-26 Mln

  • Price to Earnings info

    --

$4.22

As on 12-Aug-2022 11:07 EDT

up-down-arrow $-0.03-0.71%

  • Prev Close info

    $4.25

  • Day's Openinfo

    $4.22

  • Today's Highinfo

    $4.22

  • Today's Lowinfo

    $4.22

  • Today's Volumeinfo

    107

Please wait...

Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Armata Pharmaceuticals (ARMP)
-22.99 14.05 5.50 9.04 3.56 -16.55 -42.00
S&P BSE Sensex
2.08 9.32 9.94 9.05 16.53 13.76 12.97
S&P Small-Cap 600
-8.13 14.13 12.23 -5.78 11.43 9.16 11.05
As on 12-Aug-2022
2021
2020
2019
2018
2017
2016
2015
Armata Pharmaceuticals (ARMP)
83.59 -8.16 12.53 -79.40 -77.05 -88.94 -61.17
S&P Small-Cap 600
25.27 9.57 20.86 -9.70 11.73 24.74 -3.36
S&P BSE Sensex
21.99 15.75 14.38 5.87 27.91 1.95 -5.03

Valuation

Stock
Peer Median

Growth & Efficiency

Stock
Peer Median

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        Other Details

        CEO & Director

        Dr. Brian Varnum Ph.D.

        Advisor & Director

        Mr. Todd R. Patrick MBA

        Headquarters

        Marina del Rey, CA
        Edit edit
        Please wait...
        Please wait...

        Key Facts

        • Market cap info

          $152.49 Mln

        • Revenue (TTM) info

          $1.17 Mln

        • Earnings (TTM) info

          $-26.43 Mln

        • Cash info

          $46.41 Mln

        • Total Debt info

          $38.44 Mln

        • Insider's Holding

          70.03%

        • Liquidity info

          Low

        • 52 Week range info

          $2.82 - 6.49

        • Shares outstanding info

          36,112,100

        • 10 Years Aggregate:

          CFO: $-120.67 Mln

          EBITDA: $-136.87 Mln

          Net Profit: $-145.53 Mln

        About The Company

        • Business

          Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide.

        • IPO Date

          09-Mar-2011

        • CEO & Director

          Dr. Brian Varnum Ph.D.

        • Advisor & Director

          Mr. Todd R. Patrick MBA

        • Listing info

          NYSE: ARMP

        • Country

          United States

        • Headquarters info

          Marina del Rey, CA

        • Website info

          https://www.armatapharma.com